SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-16-006553
Filing Date
2016-03-28
Accepted
2016-03-28 16:15:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 VITAE PHARMACEUTICALS, INC. p16-0977sc13ga.htm SC 13G/A 104259
  Complete submission text file 0000902664-16-006553.txt   106045
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Subject) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88337 | Film No.: 161532410
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

IRS No.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A